Study reveals multiple high-risk genetic changes predict worse multiple myeloma outcomes across all treatments.

A couple facing a terminal multiple myeloma diagnosis finds renewed hope through innovative immunotherapy, transforming blood ...

This Myeloma Awareness Month, HealthTree Foundation, a global nonprofit dedicated to advancing cures for blood cancers through innovative technology, announces the launch of its AI-powered ...

Carrie Madormo, RN, MPH, is a health writer. She has over a decade of experience as a registered nurse, practicing in a variety of fields, such as pediatrics, oncology, chronic pain, and public ...

A groundbreaking study in Nature Medicine reveals that GD2 CAR-T cell therapy can lead to long-term remission in children ...

Survival of patients with multiple myeloma (MM) has markedly improved over the past 20 ... This study establishes ≥two HRCAs as a consistent diagnostic marker for HRMM, identifying patients with the ...

Using multiple mouse models of myeloma and mixed ... A CML cell line, K562, negative for myeloma markers was induced to express either CS1 (CS1-K562) or BCMA (BCMA-K562). After confirming ...

A 72-year-old woman with relapsed, triple-class–refractory IgA kappa multiple myeloma and a high-risk ... but which did not express TRBC1 chain (a marker for expression of a T-cell antigen ...

Bone marrow transplant is associated with accelerated brain aging and worse neurocognitive functioning, data suggest.

Operator Good afternoon, everyone, and welcome to Gilead's fourth quarter and full year 2024 earnings conference call. My name is Rebecca, and I'll be today's host. In a moment, we'll begin our ...